 |
 |
Full Text
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses...
Zhang et al. Am J Physiol Renal Physiol.2008;
295:
F1071-F1081
|
|
|
|
|
| To view this item, select one of the options below: |
|
|
|
 |
Sign In |
|
|
|
|
|
|
Purchase Short-Term Access |
|
 |
Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$8.00. |
|
|
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired. |
|
|
|
|
Sign Up |
|
|
Subscribe to the Journal - Subscribe to the print and/or online journal. |
|
|
|
|
|
Media Information |
|
|
Information for news media coverage: contact media{at}the-aps.org. |
|
|
|
|
Patient Access |
|
|
Patients who need an article - click here. |
|
|
|
